The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DNA Testing & Diagnostics Market Research Report 2025
Synopsis
DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases.
The global DNA Testing & Diagnostics market was valued at US$ 10880 million in 2023 and is anticipated to reach US$ 24190 million by 2030, witnessing a CAGR of 11.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for DNA Testing & Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Testing & Diagnostics.
Report Scope
The DNA Testing & Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Testing & Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Testing & Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
454 Life Sciences
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina
Cephide
Hologic
Transgenomic
Siemens Healthcare
Roche Diagnostics
Qiagen
Affymetrix
Agilent Technologies
Segment by Type
PCR-Based Diagnostics
ISH Diagnostics
NGS DNA Diagnosis
Segment by Application
Hospital
Medical Research
Pharmacogenomics Diagnostic Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Testing & Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases.
The global DNA Testing & Diagnostics market was valued at US$ 10880 million in 2023 and is anticipated to reach US$ 24190 million by 2030, witnessing a CAGR of 11.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for DNA Testing & Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Testing & Diagnostics.
Report Scope
The DNA Testing & Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DNA Testing & Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Testing & Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
454 Life Sciences
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina
Cephide
Hologic
Transgenomic
Siemens Healthcare
Roche Diagnostics
Qiagen
Affymetrix
Agilent Technologies
Segment by Type
PCR-Based Diagnostics
ISH Diagnostics
NGS DNA Diagnosis
Segment by Application
Hospital
Medical Research
Pharmacogenomics Diagnostic Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA Testing & Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Testing & Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR-Based Diagnostics
1.2.3 ISH Diagnostics
1.2.4 NGS DNA Diagnosis
1.3 Market by Application
1.3.1 Global DNA Testing & Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research
1.3.4 Pharmacogenomics Diagnostic Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Testing & Diagnostics Market Perspective (2019-2030)
2.2 DNA Testing & Diagnostics Growth Trends by Region
2.2.1 Global DNA Testing & Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 DNA Testing & Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 DNA Testing & Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 DNA Testing & Diagnostics Market Dynamics
2.3.1 DNA Testing & Diagnostics Industry Trends
2.3.2 DNA Testing & Diagnostics Market Drivers
2.3.3 DNA Testing & Diagnostics Market Challenges
2.3.4 DNA Testing & Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Testing & Diagnostics Players by Revenue
3.1.1 Global Top DNA Testing & Diagnostics Players by Revenue (2019-2024)
3.1.2 Global DNA Testing & Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global DNA Testing & Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by DNA Testing & Diagnostics Revenue
3.4 Global DNA Testing & Diagnostics Market Concentration Ratio
3.4.1 Global DNA Testing & Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Testing & Diagnostics Revenue in 2023
3.5 DNA Testing & Diagnostics Key Players Head office and Area Served
3.6 Key Players DNA Testing & Diagnostics Product Solution and Service
3.7 Date of Enter into DNA Testing & Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Testing & Diagnostics Breakdown Data by Type
4.1 Global DNA Testing & Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global DNA Testing & Diagnostics Forecasted Market Size by Type (2025-2030)
5 DNA Testing & Diagnostics Breakdown Data by Application
5.1 Global DNA Testing & Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global DNA Testing & Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America DNA Testing & Diagnostics Market Size (2019-2030)
6.2 North America DNA Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America DNA Testing & Diagnostics Market Size by Country (2019-2024)
6.4 North America DNA Testing & Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Testing & Diagnostics Market Size (2019-2030)
7.2 Europe DNA Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe DNA Testing & Diagnostics Market Size by Country (2019-2024)
7.4 Europe DNA Testing & Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Testing & Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific DNA Testing & Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific DNA Testing & Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific DNA Testing & Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Testing & Diagnostics Market Size (2019-2030)
9.2 Latin America DNA Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America DNA Testing & Diagnostics Market Size by Country (2019-2024)
9.4 Latin America DNA Testing & Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Testing & Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa DNA Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa DNA Testing & Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa DNA Testing & Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare DNA Testing & Diagnostics Introduction
11.1.4 GE Healthcare Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.1.5 GE Healthcare Recent Development
11.2 454 Life Sciences
11.2.1 454 Life Sciences Company Detail
11.2.2 454 Life Sciences Business Overview
11.2.3 454 Life Sciences DNA Testing & Diagnostics Introduction
11.2.4 454 Life Sciences Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.2.5 454 Life Sciences Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories DNA Testing & Diagnostics Introduction
11.3.4 Abbott Laboratories Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter DNA Testing & Diagnostics Introduction
11.4.4 Beckman Coulter Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories DNA Testing & Diagnostics Introduction
11.5.4 Bio-Rad Laboratories Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific DNA Testing & Diagnostics Introduction
11.6.4 Thermo Fisher Scientific Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina DNA Testing & Diagnostics Introduction
11.7.4 Illumina Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Cephide
11.8.1 Cephide Company Detail
11.8.2 Cephide Business Overview
11.8.3 Cephide DNA Testing & Diagnostics Introduction
11.8.4 Cephide Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.8.5 Cephide Recent Development
11.9 Hologic
11.9.1 Hologic Company Detail
11.9.2 Hologic Business Overview
11.9.3 Hologic DNA Testing & Diagnostics Introduction
11.9.4 Hologic Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.9.5 Hologic Recent Development
11.10 Transgenomic
11.10.1 Transgenomic Company Detail
11.10.2 Transgenomic Business Overview
11.10.3 Transgenomic DNA Testing & Diagnostics Introduction
11.10.4 Transgenomic Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.10.5 Transgenomic Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Detail
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare DNA Testing & Diagnostics Introduction
11.11.4 Siemens Healthcare Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.11.5 Siemens Healthcare Recent Development
11.12 Roche Diagnostics
11.12.1 Roche Diagnostics Company Detail
11.12.2 Roche Diagnostics Business Overview
11.12.3 Roche Diagnostics DNA Testing & Diagnostics Introduction
11.12.4 Roche Diagnostics Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.12.5 Roche Diagnostics Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Detail
11.13.2 Qiagen Business Overview
11.13.3 Qiagen DNA Testing & Diagnostics Introduction
11.13.4 Qiagen Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.13.5 Qiagen Recent Development
11.14 Affymetrix
11.14.1 Affymetrix Company Detail
11.14.2 Affymetrix Business Overview
11.14.3 Affymetrix DNA Testing & Diagnostics Introduction
11.14.4 Affymetrix Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.14.5 Affymetrix Recent Development
11.15 Agilent Technologies
11.15.1 Agilent Technologies Company Detail
11.15.2 Agilent Technologies Business Overview
11.15.3 Agilent Technologies DNA Testing & Diagnostics Introduction
11.15.4 Agilent Technologies Revenue in DNA Testing & Diagnostics Business (2019-2024)
11.15.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
